WORLD
Regeneron Buys Rights to Cancer Drug Libtayo from Sanofi - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Regeneron buys rights to cancer drug Libtayo from Sanofi ...'
Regeneron buys rights to cancer drug Libtayo from Sanofi https://t.co/ZRS2uHsGMT pic.twitter.com/qqMtYCPZES— Reuters (@Reuters) June 2, 2022
(The above story first appeared on LatestLY on Jun 02, 2022 06:51 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
